Aurora Cannabis Inc
As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay
Aurora Cannabis Announces Fiscal 2021 Second Quarter Results
Aurora Cannabis And Medreleaf Australia Announce Strategic Agreement
Sino Splendid Says Disposed Aggregate 30,000 Aurora Cannabis Shares For About HK$2.5 Mln
About Aurora Cannabis Inc
Aurora Cannabis Inc is a Canada-based medical cannabis company. The Company’s principal strategic business lines are focused on the production, distribution and sale of cannabis in Canada and internationally. The Company is focused on offering its cannabis products to global medical cannabis market, consumer use cannabis market and global hemp-derived cannabidiol (CBD) markets. The Company offers varieties of cannabis infused products under various brands that includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and ROAR Sports. Its products portfolio includes dried cannabis, cannabis oil, soft-gels, oral dissolve strips, edibles, vaporizers and cannabis infused chocolates.
Aurora Cannabis Inc As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay Pricing Next Event Latest Developments Aurora Cannabis Announces Fiscal 2021 Second Quarter Results
Aurora Cannabis Inc. (ACB)
|Bid||8.61 x 2200|
|Ask||8.62 x 3200|
|Day’s Range||8.55 – 8.89|
|52 Week Range||3.71 – 19.68|
|Beta (5Y Monthly)||3.16|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
B/Zmk9c3RyaW07aD0xOTM7cT04MDt3PTIyMDthcHBpZD15dGFjaHlvbg–/https://s.yimg.com/hd/cp-video-transcode/prod/2021-04/06/606cbb05901e25342b5c65b5/606cbb05901e25342b5c65b6_o_U_v2.jpg” alt=”New York competing with New Jersey for marijuana dollars” />
New York competing with New Jersey for marijuana dollars
Yahoo Finance’s Alexis Keenan, Kristin Myers, and Alexis Christoforous discuss projected cannabis market within New Jersey and New York.
B/Zmk9c3RyaW07aD0xNDQ7cT04MDt3PTE0NDthcHBpZD15dGFjaHlvbg–/https://s.yimg.com/hd/cp-video-transcode/prod/2021-04/05/606b4dc09505d72c1eba2f9b/606b68a8ae808b38306d0b57_o_U_v3.jpg” alt=”Boycott threats escalate against Georgia based companies” />
B/Zmk9c3RyaW07aD0xNDQ7cT04MDt3PTE0NDthcHBpZD15dGFjaHlvbg–/https://s.yimg.com/hd/cp-video-transcode/prod/2021-04/05/606b5d3d4cd7fe429e485e16/606b5d3d4cd7fe429e485e17_o_U_v2.jpg” alt=”Supreme Court rules in Google” />
10 Biggest Canadian Marijuana Companies
With Aphria leading the pack, these are the 10 biggest Canadian marijuana companies by 12-month trailing revenue.
3 Pot Stocks to Avoid Like the Plague in April
The cannabis industry is highly competitive, and quite a few businesses simply aren’t in great shape. The bulk of Sundial Growers’ gains since the year began are the result of the Reddit frenzy. Without (pardon the pun) getting too far into the weeds, retail investors on Reddit’s WallStreetBets chat room have essentially banded together to buy shares and out-of-the-money call options in stocks with high levels of short interest.
Could Aurora Cannabis Be a Millionaire-Maker Stock?
This pot stock was once a favorite among investors, but has fallen from grace in recent months.
B/Zmk9c3RyaW07aD0xNDQ7cT04MDt3PTE0NDthcHBpZD15dGFjaHlvbg–/https://s.yimg.com/uc/fin/img/non-sub-report-thumb.png” alt=”Analyst Report: Tilray, Inc.” />
Are Any Marijuana Stocks Good Buys As New York Legalizes?
Marijuana stocks have fallen from their February highs, but New York’s legalization of cannabis opens a potentially massive market on the East Coast.
Why Aphria, Aurora Cannabis, and Green Thumb Industries Stocks Jumped Wednesday
Cannabis stocks gained momentum as another U.S. state passed legislation to legalize recreational pot.
3 Cannabis Stocks Looking For Support
Cannabis stocks have been the talk lately as recreational legalization advances in New York. Three stocks that look to be nearing support are Tilray Inc. (NASDAQ: TLRY), Canopy Growth Corp. (NASDAQ: CGC) and Aurora Cannabis Inc. (NYSE: ACB). Tilray Daily Chart Analysis: The stock looks to be in a channel between the price levels of $20 and $35. The $20 level was a previous resistance that held as support; $35 is a place the stock struggled to break above. $35 would have to break and hold before the stock may move higher. The red line and the lows show what technical traders may call a “descending triangle” pattern. This bearish continuation pattern could move the stock down if it can break and hold below $20. A break above the red line might indicate a trend reversal. Canopy Growth Daily Chart Analysis: Canopy Growth is trading with three potential key levels. The first level is $30, a potential support that the stock is nearing. This was previously resistance that broke and held as support. A break below may send a strong bearish push toward the next support level. The next support level may be found near the $25 mark, as the stock has previously found support here. The stock has struggled to cross above the $35 level. This area may act as resistance in the future as well. A break above this area with a retest as support could move the stock higher. Aurora Cannabis Daily Chart Analysis: The daily chart above shows Aurora Cannabis is nearing a potential support level of $8. This is an area the stock broke out above, and where it was able to find support again. If the stock breaks below this level, it could see a stronger bearish move. The stock has shown it’s unable to break above the $12 level and hold for any extended period of time. This is an area where the stock may see potential resistance in the future. A break above this level with consolidation may bring the stock higher. Photo courtesy of Tilray. See more from BenzingaClick here for options trades from Benzinga2 Payments Stocks Getting In On The Crypto Craze: Visa, PayPal Chart AnalysisHumanigen Rallies 54%: A Technical Analysis© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Why There Could Be at Least 1 More Big Acquisition in the Cannabis Industry This Year
There has been a surge of mergers and acquisitions activity in the cannabis industry of late. Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) are linking up in one of the sector’s highest-profile mergers, and other industries are getting in on the action. Jazz Pharmaceuticals (NASDAQ: JAZZ) is acquiring GW Pharmaceuticals (NASDAQ: GWPH), maker of Epidiolex, a cannabis-based seizure medication, for $7.2 billion, and a subsidiary of British American Tobacco is taking a 19.9% stake in OrganiGram.
BC Craft Supply Announces $500,000 Private Placement with Strategic Investor Mr. Daniel Petrov
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co. Ltd. (the “Company” or “BC Craft”) (CSE: CRFT) (OTC:CRFTF) (FSE:ZZD1) is pleased to announce that it has entered into an agreement to complete a strategic private placement with Mr. Daniel Petrov for aggregate proceeds of $500,000 (the “Private Placement”). The Company is also pleased to announce that it has entered into a letter of intent to acquire 100% of Somo Industries Inc. dba Feelwell (the “Acquisition”). Strategic Private Placement Mr. Petrov is an accomplished cannabis industry leader with a decade of experience working with a number of successful cannabis ventures and acting as a consultant to industry-related companies worldwide. He is the current Chief Executive Officer of Kiaro Holdings Corp. (TSXV:KO), co-founder and former Executive Vice President of Aurora Cannabis (NYSE:ACB). In addition to his role as CEO, Mr. Petrov has held board positions with various cannabis companies and is part of a working group of Canadian experts that advise international governments on developing cannabis regulations. Pursuant to the Private Placement offering, the Company will sell an aggregate of 6,095,238 units in the capital of BC Craft (each a “Unit”), each Unit will be issued at a price of CAD $0.084 and comprised of one common share of the Company (each a “Common Share”) and one-half of one (1/2) common share purchase warrant (each whole warrant, a “Warrant”) of the Company. Each Warrant is exercisable to acquire one Common Share of the Company for a period of 24 months following the closing date at an exercise price of CAD $0.126 per Common Share. All securities issued or issuable pursuant to the Private Placement are subject to a hold period of four months and one day. In connection with the Private Placement, Mr. Petrov has been appointed as a member of the Company’s advisory board. As compensation for Mr. Petrov’s services as an advisory board member, the Company will grant to Mr. Petrov stock options to purchase up to an aggregate of 100,000 Common Shares at an exercise price of $0.105 per Common Share for a period of up to 5 years. The stock options are subject to the Company’s stock option plan and vest over a period of approximately five (5) months. Matthew Watters, CEO of BC Craft stated, “We are thrilled to welcome Daniel Petrov as a member of our advisory board. Daniel’s personal business and investment initiatives reflect his passion for driving innovative, high reward projects and we are delighted to be added to his ecosystem. Mr. Petrov’s addition comes at a critical time as we gain traction in market and we look forward to leveraging his experience and personal relationships in the to help shape BC Craft’s strategic direction.” For further information please contact Matthew Watters, Director, at (604) 687-2038. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. About BC Craft Supply Co. Ltd. Based in Vancouver, British Columbia, BC Craft Supply Co. has aggregated the best legacy-era talent from Canada’s craft cannabis industry, which boasts an international reputation. The team at BC Craft supports the most trusted cannabis cultivators in Canada to transition into their supply chain, bringing with them their unique cultivars and years of experience with the plant. In exchange for support with licensing, compliance and distribution, cultivators will sign on as a BC Craft supplier. This makes BC Craft uniquely positioned to be the premium cannabis brand in Canada. BC Craft’s subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a license to sell medical cannabis products in Canada. Click here to connect with BC Craft Supply Co. on Instagram, Twitter, LinkedIn and Facebook. CONTACT Matthew Watters, Direct Phone: 604-687-2038Email: [email protected] Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management. This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking information in this press release includes statements relating to Ava Pathways ability to provide access to tested and standardized naturally-derived and synthetic materials for the production of superior psychoactive and non-psychoactive formulations and the emerging psychedelic space becoming legal and social acceptable from the broader population. Although the Company believes that the material factors, expectations and assumptions expressed in such forward- looking statements are reasonable based on information available to it on the date such statements were made, no assurances can be given as to future results, levels of activity and achievements and such statements are not guarantees of future performance. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Accordingly, readers should not place undue reliance on forward-looking statements. BC Craft disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Do Options Traders Know Something About Aurora (ACB) Stock We Don’t?
Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.
This Is the Absolute Worst Marijuana Stock Money Can Buy
Meanwhile, cannabis industry analytics company BDSA is looking for Canada to generate as much as $6.4 billion in annual weed sales by 2026, up from $2.6 billion in 2020 sales. Add in Mexico, which is now waving the green flag on recreational cannabis, and it’s easy to see how the North American marijuana market could hit $50 billion in sales by 2025. With legal cannabis sales expected to grow by a double-digit annualized percentage throughout the decade, marijuana stocks are a natural favorite among investors.
Key Supplier To Pot Producers Makes Sixth Acquisition So Far This Year
GrowGeneration made its second acquisition in as many days as the marijuana growing-supplies retailer snapped up a hydroponics superstore.
Is Tilray Stock A Buy After Shoring Up Key Support Level?
Tilray has cooled down from its massive run this year, fueled by U.S. legalization prospects. Is TLRY stock a buy right now?
5 Stocks That Were Once the Most Held on Robinhood
Volatility isn’t something that the typical investor looks forward to. Online investing app Robinhood, which is well-known for offering commission-free trades, fractional share investing, and gifts free shares of stock to new members, gained 3 million new users last year. With an average age of 31 for its user base, Robinhood’s investing platform has acted as lightning rod for young investors.
Cannabis Stocks Watchlist: Organigram, Tilray Surge Higher
See how cannabis stocks such as Village Farms, Organigram Holdings, Sundial Growers, Canopy Growth and more performed in the market this past week.
Can Aurora Cannabis Grow Into Its Valuation?
Aurora Cannabis (ACB) was once the darling of the cannabis industry. In 2018, after having built Canada’s largest production capabilities, the company was eager to take on the newly legalized cannabis world. Unfortunately, success fell short and the latest earnings release sums up its inability achieve profitability. During the past two months, there have been large swings in ACB stock price. I wanted to break down the financial numbers to get a sense of what a true value of the stock could be and show what Aurora needs to accomplish to get to profitability. When we look at earnings, we try to determine future price levels based upon forward earnings multiples. Aurora Cannabis is not earning a profit, and is unlikely to become so any time soon. However, by projecting a few numbers it is possible to work through the losses and potentially glean enough information to calculate a valuation. Here is a look at the most recent revenues for Aurora: (Chart Data Source: Company Data – Author’s Chart) In Canada, where Aurora primarily operates, total retail sales for the past three months is CAD
$750M. At the same time, the latest quarter’s revenues for Aurora were some CAD $70M. That means Aurora is producing approximately 8.5% of all of Canada’s cannabis. But, Canada’s total retail sales have increased some 130% YoY from October 2019 to October 2020. Aurora has struggled to gain momentum despite being one of Canada’s largest cannabis producers. At the same time, while Aurora has produced very large amounts of cannabis, the margins the company is receiving are not competitive with the most competitive cannabis companies. After having reviewed so many cannabis companies, I can tell you that the very best companies have gross margins of
60% or more. Here are Aurora’s gross margins over the past two years: (Chart Data Source: Company Data – Author’s Chart) The smallish boutique companies tend to produce smaller amounts of cannabis but have higher gross margins. However, there are exceptions to this where there are some “boutique” cannabis companies selling comparable amounts of cannabis every quarter but, with higher margins. Aurora could feasibly maintain its current revenue levels while simultaneously increase its margins. Aurora’s business model was to produce very large quantities of wholesale cannabis. Nearly every single company that has attempted that is now on its way to finishing its restructuring phase of moving away from the wholesale side of the business and into premium branding. Aurora’s new stated goal is to achieve significant growth in its premium brands. And, with enough time, the company just might pull it off. First, if Aurora were to maintain its market share of wholesale and increase margins, this will add to the bottom line. I have looked at some 350 cannabis companies and it is difficult to find a producer who is sticking to the wholesale model. That may be an opportunity for Aurora since largely most of the other players in this field have left the game entirely. If margins from the wholesale business were to improve from their lows of 25% and push back upwards to 50%, this adds an additional $17M to gross profits. At the same time, if Aurora’s premium branding continues to increase in sales and can add some $25M to the topline, this will add an additional $15M to gross profits. With operating costs as low as $30M, Aurora Cannabis has the opportunity to start adding to the bottom line. For now, the restructuring costs are adding significant losses to the bottom line. But, even that will end shortly and the bottom line can begin to improve. So, where could that put Aurora’s stock price? Using a forward look, we can look towards total revenues, margins, and operating costs to find a possible price target. Given a future potential of $75M in revenues with an approximate 14% net profits and 168M in outstanding shares, this puts ACB at
$5.00 per share. Then, given a future growth rate of revenues and earnings, Aurora can then begin the long process of increasing shareholder value. The majority on the Street remain Aurora skeptics. The stock has a Moderate Sell consensus rating, based on 4 Holds, and 7 Sells. Although the analysts see only
6% downside, given the average price target currently stands at US$9.98. (See ACB stock analysis on TipRanks) Disclosure: No position. Disclaimer: The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities.
Find the latest Aurora Cannabis Inc. (ACB) stock quote, history, news and other vital information to help you with your stock trading and investing.